Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Skye Bioscience, Inc. Director's Dealing 2025

Apr 25, 2025

34097_dirs_2025-04-25_829a31ca-f07e-432a-912c-c386ec870d1b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Skye Bioscience, Inc. (SKYE)
CIK: 0001516551
Period of Report: 2025-04-23

Reporting Person: Twitty Christopher (Chief Scientific Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 81242 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $3.50 2033-09-29 Common Stock (17004) Direct
Stock Option (Right to Buy) $14.56 2034-02-28 Common Stock (75000) Direct
Stock Option (Right to Buy) $3.50 2033-08-25 Common Stock (7100) Direct
Stock Option (Right to Buy) $5.15 2034-10-28 Common Stock (200000) Direct
Stock Option (Right to Buy) $2.89 2035-02-24 Common Stock (150000) Direct
Stock Option (Right to Buy) $4.25 2033-01-05 Common Stock (12000) Direct

Footnotes

F1: Includes (a) 14,060 restricted stock unit ("RSU") awards that vests upon the company achieving a market capitalization of $500 million or more and (b) 25,000 RSUs that vest upon the achievement of the following performance milestones: (i) 25% vests upon the company achieving a market capitalization of $750 million and a stock price of $20.00 per share, (ii) an additional 25% vests upon the company achieving a market capitalization of $1 billion and a stock price of $25.00 per share, (iii) an additional 25% vests upon the company achieving a market capitalization of $1.25 billion and a stock price of $30.00 per share and (iv) an additional 25% vests if the company achieves a market capitalization of $1.5 billion or greater and a stock price of $35.00 per share.

F2: The stock option vests in equal monthly installments over the four year period beginning on August 24, 2023.

F3: The stock option vests in equal monthly installments over the four year period beginning February 29, 2024.

F4: The stock option vests in equal monthly installments over the four year period beginning August 24, 2023.

F5: The stock option vests in equal monthly installments over the four year period beginning October 28, 2024.

F6: The stock option vests in equal monthly installments over the one year period beginning February 21, 2025.

F7: The stock option vests 25% on December 8, 2023 and 1/48th monthly thereafter.